CHRONIC MYELOGENOUS LEUKEMIA (CML)
Clinical trials for CHRONIC MYELOGENOUS LEUKEMIA (CML) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC MYELOGENOUS LEUKEMIA (CML) trials appear
Sign up with your email to follow new studies for CHRONIC MYELOGENOUS LEUKEMIA (CML), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Supercharged cord blood offers new hope for cancer patients
Disease control CompletedThis study tested whether a new, lab-expanded cord blood transplant (called NiCord) works better than a standard cord blood transplant for patients with blood cancers like leukemia and lymphoma. The goal was to see if the expanded cells help patients recover their immune systems …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: PHASE3 • Sponsor: Gamida Cell ltd • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
One donor, two transplants: experimental procedure aims to cure blood cancer and fix kidneys
Disease control CompletedThis pilot study tested a combined transplant from a partially matched family donor. It aimed to treat patients who had both a serious blood disorder (like leukemia) and advanced kidney disease at the same time. The goal was to cure the blood disorder and restore kidney function …
Matched conditions: CHRONIC MYELOGENOUS LEUKEMIA (CML)
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC